News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
KURIYEL RALF
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/16/2023 |
4
| KURIYEL RALF (Senior VP, R&D) has filed a Form 4 on REPLIGEN CORP|
Txns:
| Paid exercise price by delivering 710 shares
@ $154.03, valued at
$109.4k
|
|
| 03/06/2023 |
4
| KURIYEL RALF (Senior VP, R&D) has filed a Form 4 on REPLIGEN CORP|
Txns:
| Granted 3,468 shares
@ $0
Granted 3,591 shares
@ $0
Paid exercise price by delivering 1,247 shares
@ $188, valued at
$234.4k
Granted 3,591 options to buy
@ $180.48, valued at
$648.1k
|
|
| 03/01/2023 |
4
| KURIYEL RALF (Senior VP, R&D) has filed a Form 4 on REPLIGEN CORP|
Txns:
| Paid exercise price by delivering 358 shares
@ $173.28, valued at
$62k
|
|
| 02/28/2023 |
4
| KURIYEL RALF (Senior VP, R&D) has filed a Form 4 on REPLIGEN CORP|
Txns:
| Paid exercise price by delivering 458 shares
@ $173.44, valued at
$79.4k
|
|
| 08/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/02/2021 |
4
| KURIYEL RALF (Senior VP, R&D) has filed a Form 4 on REPLIGEN CORP|
Txns:
| Sold 4,001 shares
@ $282.13, valued at
$1.1M
|
|
| 06/14/2021 |
4
| KURIYEL RALF (Senior VP, R&D) has filed a Form 4 on REPLIGEN CORP|
Txns:
| Sold 6,802 shares
@ $189.19, valued at
$1.3M
Exercised 2,557 options to buy
@ $59.52, valued at
$152.2k
Exercised 1,045 options to buy
@ $86.1, valued at
$90k
|
|
| 05/18/2021 |
4
| KURIYEL RALF (Senior VP, R&D) has filed a Form 4 on REPLIGEN CORP|
Txns:
| Sold 710 shares
@ $172.29, valued at
$122.3k
|
|
| 03/12/2021 |
4
| KURIYEL RALF (Senior VP, R&D) has filed a Form 4 on REPLIGEN CORP|
Txns:
| Sold 6,354 shares
@ $190.08, valued at
$1.2M
Sold 642 shares
@ $191.33, valued at
$122.8k
Sold 1,004 shares
@ $192.13, valued at
$192.9k
Exercised 2,000 options to buy
@ $33.05, valued at
$66.1k
Exercised 5,850 options to buy
@ $33.87, valued at
$198.1k
Exercised 150 options to buy
@ $59.52, valued at
$8.9k
|
|
| 03/08/2021 |
4
| KURIYEL RALF (Senior VP, R&D) has filed a Form 4 on REPLIGEN CORP|
Txns:
| Sold 400 shares
@ $196.23, valued at
$78.5k
Sold 25 shares
@ $194.3, valued at
$4.9k
Sold 350 shares
@ $192.24, valued at
$67.3k
Sold 600 shares
@ $191.2, valued at
$114.7k
Sold 700 shares
@ $190.06, valued at
$133k
|
|
| 02/26/2021 |
4
| KURIYEL RALF (Senior VP, R&D) has filed a Form 4 on REPLIGEN CORP|
Txns:
| Granted 1,686 shares
@ $0
Granted 2,035 options to buy
@ $215.58, valued at
$438.7k
|
|
| 12/18/2020 |
4
| KURIYEL RALF (Senior VP, R&D) has filed a Form 4 on REPLIGEN CORP|
Txns:
| Sold 435 shares
@ $186.18, valued at
$81k
|
|
| 08/10/2020 |
4
| KURIYEL RALF (Senior VP, R&D) has filed a Form 4 on REPLIGEN CORP|
Txns:
| Sold 5,000 shares
@ $153.79, valued at
$769k
Exercised 5,000 options to buy
@ $33.87, valued at
$169.4k
|
|
| 05/19/2020 |
4
| KURIYEL RALF (Senior VP, R&D) has filed a Form 4 on REPLIGEN CORP|
Txns:
| Sold 435 shares
@ $140.69, valued at
$61.2k
|
|
| 05/15/2020 |
4
| KURIYEL RALF (Senior VP, R&D) has filed a Form 4 on REPLIGEN CORP|
Txns:
| Sold 1,612 shares
@ $126.88, valued at
$204.5k
Sold 6,293 shares
@ $128.02, valued at
$805.6k
Sold 95 shares
@ $128.55, valued at
$12.2k
Exercised 6,000 options to buy
@ $33.05, valued at
$198.3k
Exercised 2,000 options to buy
@ $33.87, valued at
$67.7k
|
|
| 03/05/2020 |
4
| KURIYEL RALF (Senior VP, R&D) has filed a Form 4 on REPLIGEN CORP|
Txns:
| Sold 450 shares
@ $88.35, valued at
$39.8k
Sold 650 shares
@ $90.08, valued at
$58.6k
Sold 1,905 shares
@ $90.99, valued at
$173.3k
|
|
| 03/02/2020 |
4
| KURIYEL RALF (Senior VP, R&D) has filed a Form 4 on REPLIGEN CORP|
Txns:
| Granted 3,216 shares
@ $0
Granted 3,137 options to buy
@ $86.1, valued at
$270.1k
|
|
| 02/27/2020 |
4
| KURIYEL RALF (Senior VP, R&D) has filed a Form 4 on REPLIGEN CORP|
Txns:
| Sold 195 shares
@ $86.6, valued at
$16.9k
|
|
| 12/18/2019 |
4
| KURIYEL RALF (Senior VP, R&D) has filed a Form 4 on REPLIGEN CORP|
Txns:
| Paid exercise price by delivering 295 shares
@ $90.43, valued at
$26.7k
|
|
| 06/11/2019 |
4/A
| KURIYEL RALF (Senior VP, R&D) has filed a Form 4 on REPLIGEN CORP|
Txns:
| Granted 4,061 options to buy
@ $59.52, valued at
$241.7k
|
|
| 05/15/2019 |
4
| KURIYEL RALF (Senior VP, R&D) has filed a Form 4 on REPLIGEN CORP|
Txns:
| Granted 8,000 shares
@ $0 |
|
| 03/05/2019 |
4
| KURIYEL RALF (Senior VP, R&D) has filed a Form 4 on REPLIGEN CORP|
Txns:
| Granted 4,700 shares
@ $0
Sold 2,240 shares
@ $58.53, valued at
$131.1k
|
|
| 03/04/2019 |
4
| KURIYEL RALF (Senior VP, R&D) has filed a Form 4 on REPLIGEN CORP|
Txns:
| Granted 4,234 shares
@ $0
Sold 185 shares
@ $59.16, valued at
$10.9k
Granted 4,042 options to buy
@ $59.52, valued at
$240.6k
|
|
| 12/20/2018 |
4
| KURIYEL RALF (Senior VP, R&D) has filed a Form 4 on REPLIGEN CORP|
Txns:
| Sold 311 shares
@ $54.44, valued at
$16.9k
|
|
| 03/06/2018 |
3/A
| KURIYEL RALF (Senior VP, R&D) has filed a Form 3/A on REPLIGEN CORP |
| 03/05/2018 |
4
| KURIYEL RALF (Senior VP, R&D) has filed a Form 4 on REPLIGEN CORP|
Txns:
| Granted 6,643 shares
@ $0
Granted 12,850 options to buy
@ $33.87, valued at
$435.2k
|
|
| 03/05/2018 |
3
| KURIYEL RALF (Senior VP, R&D) has filed a Form 3 on REPLIGEN CORP |
|
|